Association between serum homocysteine and oxidative stress in elderly patients with obstructive sleep apnea/hypopnea syndrome

Biomedical and Environmental Sciences

Volumn 23, Issue 1, 2010, Pages 42-47

  Wang, Ling ^a   Li, Jie ^a   Xie, Yan ^a   Zhang, Xue Guang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Elderly; Glutathione; Homocysteine; Malonaldehyde; Obstructive sleep apnea hypopnea syndrome; Oxidative stress

Indexed keywords

EID: 77952123809     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-3988(10)60030-X     Document Type: Article

References (26)

1. 1. Shahar E, Whitney C W, Redline S, et al. (2001). Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163, 19-25. (Pubitemid 32095247)
2. 2. Lopez-Jimenez F, Sert Kuniyoshi F H, Garni A, et al. (2003). Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290, 1906-1914. (Pubitemid 37430608)
3. 3. Ryan S, Taylor C T, McNicholas W T (2006). Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 174(7), 824-830. (Pubitemid 44511665)
4. 4. Willems F F, Aengevaeren W R, Boers G H, et al. (2002). Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease. J Am Coll Cardiol 40(4), 766-772. (Pubitemid 34925625)
5. 5. Lavie L, Perelman A, Lavie P (2001). Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity. Chest 120, 900-908. (Pubitemid 32885467)
6. 6. Kokturk O, Ulukavak Ciftci T, Mollarecep E, et al. (2006). Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome. Respir Med 100, 536-541. (Pubitemid 43239888)
7. American Academy of Sleep Medicine Task Force (1999). Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22, 667-689.
8. 8. Goldman S E, Hall M, Boudreau R, et al. (2008). Association between nighttime sleep and napping in older adults. Sleep 31, 733-740. (Pubitemid 351694261)
9. CI S P, XU S X, GUO J W, et al. (2003). Research of relationship between sleep apnea syndrome and multiple organ disorders. Practical Geraeology 17(6), 304.
10. 10.Varela-Moreiras G, Escudero J M, Alonso-Aperte E (2007). Homocysteine related vitamins and lifestyles in the elderly people: The SENECA study. Nutr Hosp 22(3), 363-370. (Pubitemid 46888667)
11. Nygård O, Nordrehaug J E, Refsum H, et al. (2005).Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337, 230-236.
12. 12.Sacco R L, Anand K, Lee H S, et al. (2004). Homocysteine and the risk of ischemic stroke in a triethnic cohort: The Northern Manhattan Study. Stroke 35, 2263-2269. (Pubitemid 39311247)
13. Wuillemin W A, solenthaler M (1999). Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis. Vasa 28, 151-155.
14. 14.Can M, Açikgöz S, Mungan G, et al. (2006). Serum cardiovascular risk factors in obstructive sleep apnea. Chest 129(2), 233-237. (Pubitemid 43289839)
15. 15.Jordan W, Berger C, Cohrs S, et al. (2004). CAPA-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome. J Neural Transm 111, 683-689. (Pubitemid 38716548)
16. 16.Kokturk O, Ciftci TU, Mollarecep E, et al. (2006) .Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome. Respir Med 100, 536-541. (Pubitemid 43239888)
17. 17.Svatikova A, Wolk R, Magera M J, et al. (2004). Plasma homocysteine in obstructive sleep apnea. Eur Heart J 25, 1325-1329. (Pubitemid 38998509)
18. Cheng C H, Huang M C, Liu S C (2006). Traditional cardiovascular risk factors but not homocysteine are associated with obstructive sleep apnea. Nutr Res 26, 59-64.
19. 19.Ryan S, Nolan G M, Hannigan E, et al. (2007). Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62(6), 509-514. (Pubitemid 46910129)
20. Lavie L (2003). Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7, 35-51.
21. Christou K, Markoulis N, Moulas A N (2003). Reactive oxygen metabolites(ROMs)as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath 7, 105-110.
22. 22.Suzuki Y J, Jain V, Park A M, et al. (2006). Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 40, 1683-1692. (Pubitemid 44308121)
23. 23.Yamauchi M, Kimura H (2008). Oxidative Stress in Obstructive Sleep Apnea: Putative pathways to the Cardiovascular Complications. AntioxidRedox Signal 10, 755-768. (Pubitemid 351225902)
24. 24.Christou K, Moulas A N, Pastaka C, et al. (2003). Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 4, 225-228. (Pubitemid 36748608)
25. 25.Barceló A, Barbé F, de la Peña M, et al. (2006). Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27,756-760. (Pubitemid 44914199)
26. Pack A I (2006). Advances in sleep-disordered breathing. Am J Respir Crit Care Med 173(1), 7-15.